http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H03106816-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a452aeb7f766d55db6921d784361b891
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472
filingDate 1989-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c520fe1fb6657e2de32b7cd15e261ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98784f5cdfd20ea7c62de446cc1b85c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc5832d8c5e2c4577a1639053ad7091c
publicationDate 1991-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H03106816-A
titleOfInvention Instillation for glaucoma therapy
abstract PURPOSE: To provide the title instillation containing an isoquinolinone derivative and, as stabilizer, a phenolic hydroxyl group-contg. compound and/or glycol. n CONSTITUTION: The objective instillation can be obtained by dissolving in an appropriate base (A) as active ingredient, an isoquinolinone derivative of the formula (R 1 is H or lower alkyl; R 2 is lower alkyl) or its acid-added salt so as to be 0. 1-5w/v% in the content and (B) as stabilizer, a phenolic hydroxyl group-contg. compound (e. g. phenol) and/or glycol so as to be 0. 02-10w/v% in the content, followed by sterilization treatment. The present instillation can be additionally incorporated with such ingredient(s) as dissolution aid, thickening agent, buffering agent, antioxidant or preservative. For the present instillation, 0. 005-2.5mg per adult/day of the active ingredient should be administered once or in several portions a day. n COPYRIGHT: (C)1991,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5577779-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009058109-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008167601-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008071685-A
priorityDate 1989-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439668
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439669
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586959
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14941465
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10284

Total number of triples: 31.